THE PARKER LAB
for Applied Proteomics, Personalized Medicine, and HIV Prevention seeks to improve HIV prevention strategies in disproportionately affected communities. We are especially passionate about understanding how microbes interact with host cells and how this increases risk for disease. We employ multi-omics, systems biology, immunology and computational approaches to characterize innate immune responses to pathogenic stimuli known to increase HIV risk.
In the Parker lab, we study how cells are reprogrammed by their environment, especially in contexts that are known to increase HIV risk.
Our work has global reach, and we use multi-omic tools to assess mechanisms of microbe-mediated inflammation. Our work has implications in TB, HIV, Cancer, and Women’s Health.
GLOBAL IMPACT
We are excited to incorporate ideas from diverse perspectives. We aim to do research that will have broad impact and alleviate health disparities through our collaborative work. We are passionate about education and nutrition as a means to prevent chronic inflammatory diseases. These include community-participatory research citizen scientist projects, and women's health.
Our Clinical Collaborators
Robert Cook M.D, MPH
Director of Southern HIV & Alcohol Research Consortium
Paul Crispen, MD
UF Health Urology
Mehmet Genc, M.D., PhD
